AEs
| AE . | No. . | % . | 95% CI . |
|---|---|---|---|
| Increased ALT | 2 | 1.7 | 0.31-5.24 |
| Increased AST | 2 | 1.7 | 0.31-5.24 |
| Increased indirect bilirubin | 6 | 5.2 | 2.30-9.61 |
| Thrombocytosis | 3 | 2.6 | 0.71-6.43 |
| Abdominal reactions | 3 | 2.6 | 0.71-6.43 |
| Rash | 1 | 0.9 | 0.04-3.96 |
| Upper respiratory tract infection | 14 | 12.1 | 7.61-17.68 |
| Increased ALP | 16 | 13.8 | 8.91-19.88 |
| AE . | No. . | % . | 95% CI . |
|---|---|---|---|
| Increased ALT | 2 | 1.7 | 0.31-5.24 |
| Increased AST | 2 | 1.7 | 0.31-5.24 |
| Increased indirect bilirubin | 6 | 5.2 | 2.30-9.61 |
| Thrombocytosis | 3 | 2.6 | 0.71-6.43 |
| Abdominal reactions | 3 | 2.6 | 0.71-6.43 |
| Rash | 1 | 0.9 | 0.04-3.96 |
| Upper respiratory tract infection | 14 | 12.1 | 7.61-17.68 |
| Increased ALP | 16 | 13.8 | 8.91-19.88 |
CI, confidence interval.